The lymphoid system in hepatitis C virus infection: Autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy

Seminars in Liver Disease

Volumn 20, Issue 2, 2000, Pages 143-157

  Dammacco, F ^a   Sansonno, D ^a   Piccoli, C ^a   Racanelli, V ^a   D'Amore, F P ^a   Lauletta, G ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Autoimmunity; Hepatitis C virus; Lymphoproliferation

Indexed keywords

CD5 ANTIGEN; RHEUMATOID FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CRYOGLOBULINEMIA; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHATIC SYSTEM; LYMPHOCYTE SUBPOPULATION; PREVALENCE; PRIORITY JOURNAL;

EID: 0033867014     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9613     Document Type: Article

References (135)

1. Hepatitis C. A multifaced disease. Review of extrahepatic manifestations
2. A role for hepatitis C virus infection in type II cryoglobulinemia
3. Mixed cryoglobulinaemia: A cross-road between autoimmune and lymphoproliferative disorders
4. Autoimmune hepatitis
5. Autoimmune hepatitis: The lesson of the discovery of hepatitis C virus
6. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
7. Hepatitis C virus and autoimmunity: Fortuitous association or reality?
8. Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus
9. Mixed cryoglobulinemia as a model of systemic vasculitis
10. Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection
11. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease
12. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
13. Antigen receptor signaling gives lymphocytes a long life
14. B-cell superantigens: Implications for selection of the human antibody repertoire
15. B-cell superantigens
16. CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences
17. Rabbit appendix: A site of the development and selection of the B cell repertoire
18. The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire
19. CD5 and other superantigens as 'ticklers' of the B-cell receptor
20. + B cells and autoimmunity
21. B-1 cells: Unique origins and functions
22. The physiology of germinal centers
23. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expresses V(H) region gene
24. A systematic approach to defining the germline gene counterparts of a mutated autoantibody from a patient with rheumatoid arthritis
25. Anti-GOR and antithyroid auto-antibodies in patients with chronic hepatitis C
26. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, geno-types and liver disease severity
27. Anti-GOR and hepatitis C virus in autoimmune liver diseases
28. Reactivity of smooth-muscle antibodies with F- and G-actin
29. Meeting report. International autoimmune hepatitis group
30. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis
31. ANAs and antibodies to DNA: Their use in clinical diagnosis
32. Microsomal antibodies in active chronic hepatitis and other disorders
33. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of 'autoimmune' hepatitis
34. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis
35. Microsomal autoantibodies in chronic infection with HBsAg associated δ (delta) agent
36. Non-organ specific autoantibodies in children with chronic hepatitis C
37. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes
38. Liver/kidney microsome antibody type 1 and hepatitis C virus infection
39. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C
40. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease
41. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis
42. Autoantibodies to isolated human hepatocyte plasma membranes in chronic active hepatitis II. Specificity of antibodies
43. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy
44. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome
45. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases
46. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia
47. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: Case report and literature review
48. The intraportal lymphoid nodule and its environment in chronic hepatitis C: An immunohistochemical study
49. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis
50. Immunohistological findings in Hashimoto's thyroiditis, focal lymphocytic thyroiditis and thyroiditis de Quervain. Comparative study
51. + B cells cultured from the vitreous in acute sympathetic ophthalmitis
52. The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis
53. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis
54. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted Vκ gene utilization, junctional VκJκ and VλJλ, diversity, and somatic hypermutation
55. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C
56. IgM rheumatoid factors react with human class I HLA molecules
57. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia
58. Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspective
59. Hepatitis C virus infection and mixed cryoglobulinemia: A striking association
60. Hepatitis C virus in patients with cryoglobulinemia type II
61. Association between hepatitis C virus and mixed cryoglobulinemia
62. Mixed cryoglobulinemia and hepatitis C virus
63. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes
64. Relationship of tissue deposits of cryoglobulin to clinical features of mixed cryoglobulinemia
65. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis
66. Mixed cryoglobulinemia cross-reactive idiotypes: Implications for the relationship of MC to rheumatic and lymphoproliferative diseases
67. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins
68. Regulatory arms of the immune network
69. Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds
70. A solution to the rheumatoid factor paradox. Pathologic rheumatoids factors can be tolerized by competition with natural rheumatoid factors
71. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response
72. New roles for rheumatoid factor
73. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation
74. Complete amino acid sequences of variable regions of two human IgM rheumatoid factors, BOR and KAS of the Wa idiotypic family, reveal restricted use of heavy and light chain variable and joining region gene segments
75. Evidence for somatic selection of natural autoantibodies
76. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation
77. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia
78. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG
79. V(H)DJ(H) gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells. Evidence for somatic selection
80. Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding
81. Rheumatoid factors in immune complexes of patients with rheumatoid arthritis
82. Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated
83. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome
84. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen
85. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma
86. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia
87. Hepatitis C virus and non-Hodgkin's lymphomas
88. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders
89. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy
90. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection
91. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
92. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course
93. Primary hepatic lymphoma in a patient with chronic hepatitis C
94. Primary lymphoplasmacytic lymphoma of the liver associated with a serum monoclonal peak ofIgG κ
95. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia
96. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection
97. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma
98. Malignant lymphoproliferative disorders in liver cirrhosis
99. Hepatocellular carcinoma and B-cell tumors
100. Primary hepatic lymphoma in a man with chronic hepatitis C
101. Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection
102. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia
103. Gammapathie monoclonale apparemment non myelomateuse associe a l'antigene de l'hepatite non-A non-B
104. Monoclonal gammopathy in chronic active hepatitis
105. HCV and monoclonal gammopathies
106. Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia
107. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection
108. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
109. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy
110. Viruses in human cancers
111. In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma
112. Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C
113. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral RNA in various tissues
114. Studies on the nature of Dengue virus. III. RNA synthesis in cells infected with type 2 Dengue virus
115. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype
116. Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons
117. Characterization of long-term cultures of hepatitis C virus
118. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice
119. Hepatitis C virus RNA in peripheral blood mononuclear cells: Comparing acute and chronic hepatitis C virus infection
120. Hepatitis C virus infection involves CD34+ hematopoietic progenitor cells in hepatitis C virus chronic carriers
121. CD34: Structure, biology, and clinical utility
122. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver
123. Presence of hematopoietic stem cells in the adult liver
124. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection
125. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: An emerging picture
126. Extranodal lymphomas associated with hepatitis C virus infection
127. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection
128. Primary hepatic diffuse large B-cell lymphoma in a patient with chronic hepatitis C
129. The role of hepatitis C virus in the aetiology of non-Hodgkin's lymhoma. A regional association?
130. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center
131. No association between hepatitis C and B-cell lymphoma
132. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype